184 related articles for article (PubMed ID: 17018294)
1. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2.
Roscic A; Möller A; Calzado MA; Renner F; Wimmer VC; Gresko E; Lüdi KS; Schmitz ML
Mol Cell; 2006 Oct; 24(1):77-89. PubMed ID: 17018294
[TBL] [Abstract][Full Text] [Related]
2. Control of nuclear HIPK2 localization and function by a SUMO interaction motif.
de la Vega L; Fröbius K; Moreno R; Calzado MA; Geng H; Schmitz ML
Biochim Biophys Acta; 2011 Feb; 1813(2):283-97. PubMed ID: 21145359
[TBL] [Abstract][Full Text] [Related]
3. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.
Winter M; Sombroek D; Dauth I; Moehlenbrink J; Scheuermann K; Crone J; Hofmann TG
Nat Cell Biol; 2008 Jul; 10(7):812-24. PubMed ID: 18536714
[TBL] [Abstract][Full Text] [Related]
4. A role for non-covalent SUMO interaction motifs in Pc2/CBX4 E3 activity.
Merrill JC; Melhuish TA; Kagey MH; Yang SH; Sharrocks AD; Wotton D
PLoS One; 2010 Jan; 5(1):e8794. PubMed ID: 20098713
[TBL] [Abstract][Full Text] [Related]
5. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
[TBL] [Abstract][Full Text] [Related]
6. Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation.
Sung KS; Go YY; Ahn JH; Kim YH; Kim Y; Choi CY
FEBS Lett; 2005 Jun; 579(14):3001-8. PubMed ID: 15896780
[TBL] [Abstract][Full Text] [Related]
7. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
Zhang J; Goodson ML; Hong Y; Sarge KD
J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
[TBL] [Abstract][Full Text] [Related]
8. Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability.
Gresko E; Möller A; Roscic A; Schmitz ML
Biochem Biophys Res Commun; 2005 Apr; 329(4):1293-9. PubMed ID: 15766567
[TBL] [Abstract][Full Text] [Related]
9. Pc2 and SUMOylation.
Wotton D; Merrill JC
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1401-4. PubMed ID: 18031231
[TBL] [Abstract][Full Text] [Related]
10. PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage.
Gresko E; Ritterhoff S; Sevilla-Perez J; Roscic A; Fröbius K; Kotevic I; Vichalkovski A; Hess D; Hemmings BA; Schmitz ML
Oncogene; 2009 Feb; 28(5):698-708. PubMed ID: 19015637
[TBL] [Abstract][Full Text] [Related]
11. The SUMO E3 ligase activity of Pc2 is coordinated through a SUMO interaction motif.
Yang SH; Sharrocks AD
Mol Cell Biol; 2010 May; 30(9):2193-205. PubMed ID: 20176810
[TBL] [Abstract][Full Text] [Related]
12. An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response.
Calzado MA; de la Vega L; Möller A; Bowtell DD; Schmitz ML
Nat Cell Biol; 2009 Jan; 11(1):85-91. PubMed ID: 19043406
[TBL] [Abstract][Full Text] [Related]
13. DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation.
Pelisch F; Pozzi B; Risso G; Muñoz MJ; Srebrow A
J Biol Chem; 2012 Aug; 287(36):30789-99. PubMed ID: 22825850
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of HIPK2 by escape from proteasomal degradation mediated by the E3 ubiquitin ligase Siah1.
Kim SY; Choi DW; Kim EA; Choi CY
Cancer Lett; 2009 Jul; 279(2):177-84. PubMed ID: 19250734
[TBL] [Abstract][Full Text] [Related]
15. Multiple activities contribute to Pc2 E3 function.
Kagey MH; Melhuish TA; Powers SE; Wotton D
EMBO J; 2005 Jan; 24(1):108-19. PubMed ID: 15592428
[TBL] [Abstract][Full Text] [Related]
16. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.
Weger S; Hammer E; Heilbronn R
FEBS Lett; 2005 Sep; 579(22):5007-12. PubMed ID: 16122737
[TBL] [Abstract][Full Text] [Related]
17. TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins.
Pungaliya P; Kulkarni D; Park HJ; Marshall H; Zheng H; Lackland H; Saleem A; Rubin EH
J Proteome Res; 2007 Oct; 6(10):3918-23. PubMed ID: 17803295
[TBL] [Abstract][Full Text] [Related]
18. The polycomb protein Pc2 is a SUMO E3.
Kagey MH; Melhuish TA; Wotton D
Cell; 2003 Apr; 113(1):127-37. PubMed ID: 12679040
[TBL] [Abstract][Full Text] [Related]
19. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
Crone J; Glas C; Schultheiss K; Moehlenbrink J; Krieghoff-Henning E; Hofmann TG
Cancer Res; 2011 Mar; 71(6):2350-9. PubMed ID: 21248071
[TBL] [Abstract][Full Text] [Related]
20. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling.
Oh Y; Chung KC
J Biol Chem; 2012 May; 287(21):17517-17529. PubMed ID: 22467880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
